
A leading provider of
innovative DNA Screening solutions
Synovial sarcomas account for up to 10 percent of soft-tissue sarcomas, typically arising in the para-articular regions in adolescent and young adults1. A characteristic SYT-SSX fusion gene resulting from the chromosomal translocation t(X;18)(p11;q11) is detectable in 90% of synovial sarcomas suggesting this is the primary causal event in the sarcoma2. The translocation fuses the SYT (Synaptotagmin) gene from chromosome 18 to either of two highly homologous genes at Xp11, SSX1 (Synovial Sarcoma X Breakpoint 1) or SSX2 or in less than 1% of cases SSX43. SYT-SSX1 and SYT-SSX2 are thought to disrupt transcription and the expression of specific target genes4,5.
Cat. No. LPS 014
These products are only available labelled as Analyte Specific Reagents (ASR) in the USA.
Developed &